期刊文献+

过氧化物酶增殖体激活受体β在急性肺损伤大鼠肺组织的表达及其意义 被引量:1

Expression of peroxisome proliferation activated receptor-β in lung of rats with acute lung injury by lipopolysaccharide
下载PDF
导出
摘要 目的观察内毒素(lipopolysaccharide,LPS)复制的急性肺损伤(acutelunginjury,ALI)大鼠肺组织过氧化物酶增殖体激活受体β(peroxisomeproliferationactivatedreceptorβ,PPARβ)表达的变化,探讨PPARβ在ALI中可能的作用。方法将40只雄性Wistar大鼠随机分为对照组、LPS致伤1、2、4h组和8h组。用LPS(5mg/kg)静脉注射复制大鼠ALI模型,分别在LPS致伤后1、2、4、8h时活杀大鼠,测定各组肺组织湿/干重比(W/D)及肺组织病理变化;采用RTPCR法检测肺组织中PPARβmRNA的表达;采用免疫组化法检测肺组织中PPARβ的表达。结果LPS致伤后2、4、8h肺组织W/D较对照组均显著升高(F=19.61,P<0.01);LPS致伤后1、2、4hPPARβmRNA表达分别较对照组显著升高(F=86.96,P<0.01);而LPS致伤后2、4、8h组PPARβ表达阳性细胞光密度值较对照组显著升高(F=6.89,P<0.05)。结论PPARβ在ALI大鼠肺组织表达升高,提示其可能参与了急性肺损伤的发生发展。 Objective To investigate the expression and role of peroxisome proliferation activated receptor- β (PPARβ) in lung of rats stimulated with lipopolysaccharide (LPS). Methods Thirty-two male Wistar rats were established into acute lung injury models by venous injection of LPS and another eight LPS were injected with normal saline as controls. All rats were sacrificed at 1 , 2, 4, 8 h after injection of 5 mg/kg LPS. The ratio of lung wet/dry weight were measured. Semi-quantitative reverse transcription polymerase chain reaction ( RTPCR) and immunohistochemical method were used to measure the expression of PPARβ mRNA and PPARβ protein in the lung. Results The ratio of lung wet/dry weight in rats killed at 2 h, 4 h and 8 h after LPS injection was significantly higher than that of control group ( F = 19.61, P 〈 0. 01 ). The expression of PPARβ mRNA (IOD) in rats killed at 1 h, 2 h and 4 h after LPS injection was significantly higher than that in control group (F = 86.96, P 〈0. 01 ) and PPARβ(IOD) at 2 h, 4 h and 8 h were significantly higher than that in control group (F = 6.89, P 〈 0. 05). Conclusion Our data showed the expression of PPARβ was high in rat lung and PPARβ maybe play a major role in acute lung injury.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2005年第20期2012-2015,共4页 Journal of Third Military Medical University
基金 全军医学科学技术研究"十五"计划指令性课题(01Z074)~~
关键词 过氧化物酶增殖体激活受体 急性肺损伤 炎症反应 peroxisome proliferator-activated receptors acute lung injury inflammation
  • 相关文献

参考文献10

  • 1Willson T M, Brown P J, Sternbach D D, et al. The PPARs: from orphan receptors to drug discovery[J]. J Med Chem, 2000, 43(4): 527-550.
  • 2Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors [J]. Lancet, 1999, 354(9173): 141-148.
  • 3Jove M, Laguna J C, Vazquez Carrera M. Agonist-induced activation releases peroxisome proliferator-activated receptor β/δ from its inhibition by palmitate-induced nuclear factor-κB in skeletal muscle cells[J]. Biochim Biophys Acta, 2005, 1734(1): 52-61.
  • 4Braissant O, Foufelle F, Scotto C, et al. Differential expression of peroxisome proliferator-activated receptors(PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat [J]. Endocrinology, 1996, 137(1): 354-366.
  • 5Inoue K, Kawahito Y, Tsubouchi Y, et al. Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer [J]. Anticancer Res, 2001, 21(4A): 2471-2476.
  • 6Clark R B. The role of PPARs in inflammation and immunity[J]. J Leukoc Biol, 2002, 71(3): 388-400.
  • 7Yang H, Young D W, Gusovsky F, et al. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1[J]. J Biol Chem, 2000, 275(27): 20861-20866.
  • 8钱桂生,王建春.急性呼吸窘迫综合征研究进展[J].第三军医大学学报,2004,26(10):843-844. 被引量:19
  • 9Delerive P, Gervois P, Fruchart J C, et al. Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators [J]. J Biol Chem, 2000, 275(47): 36703-36707.
  • 10姜鹏,王建春,钱桂生.过氧化物酶增殖体激活受体α mRNA在急性肺损伤大鼠肺组织表达的变化[J].中国急救医学,2005,25(6):439-441. 被引量:3

二级参考文献22

  • 1Atabai K, Matthay M A. The pulmonary physician in critical care. 5: Acute lung injury and the acute respiratory distress syndrome: definitions and epidemiology[J]. Thorax, 2002, 57(5): 452-458.
  • 2Bellingan G J. The pulmonary physician in critical care* 6: The pathogenesis of ALI/ARDS[J]. Thorax, 2002, 57(6): 540-546.
  • 3Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome[J]. J Pathol, 2004, 202(2): 145-156.
  • 4Sartori C, Matthay M A. Alveolar epithelial fluid transport in acute lung injury: new insights[J]. Eur Respir J, 2002, 20(5): 1299-1313.
  • 5Villar J, Flores C, Mendez-Alvarez S. Genetic susceptibility to acute lung injury[J]. Crit Care Med, 2003, 31(4 Suppl): S272-275.
  • 6Brower R, Rubenfeld G D. Lung-protective ventilation strategies in acute lung injury[J]. Crit Care Med, 2003, 31(4 Suppl): S312-316.
  • 7Pinhu L, Whitehead T, Evans T, et al. Ventilator-associated lung injury[J]. Lancet, 2003, 361(9354): 332-340.
  • 8Cordingley J J, Keogh B F. The pulmonary physician in critical care c 8: Ventilatory management of ALI/ARDS[J]. Thorax, 2002, 57(8): 729-734.
  • 9Tasaka S, Hasegawa N, Ishizaka A. Pharmacology of acute lung injury[J]. Pulmn Pharmacol Ther, 2002, 15(2): 83-95.
  • 10Groeneveld A B. Vascular pharmacology of acute lung injury and acute respiratory distress syndrome[J]. Vascul Pharmacol, 2003, 39(4-5): 247-256.

共引文献20

同被引文献9

  • 1姜鹏,王建春,钱桂生.过氧化物酶增殖体激活受体与炎症及免疫反应[J].生命的化学,2005,25(3):232-235. 被引量:8
  • 2Moraes L A, Piqueras L, Bishop-Bailey D. Peroxisome proliferator-activated activated receptor and inflammation [ J ]. Phar Ther, 2006, 110 (3) : 371-385.
  • 3Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome [ J ]. J Pathol, 2004, 202(2) : 145-156.
  • 4Belvisi M G, Hele D J, Birrell M A. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation [J]. Eur J Pharmacol, 2006, 533( 1-3) : 101-109.
  • 5Braissant O, Foufelle F, Scotto C, et al. Differential expression of peroxisome proliferator-activated receptors (PPARs) : tissue distribution of PPAR-alpha, -beta and -gamma in the adult rat [ J ]. Endocrinology, 1996, 137(1) : 354-366.
  • 6Patel H J, Belvisi M G, Bishop-Bailey D, et al. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy [ J ]. J Immunol, 2003, 170 (5) : 2663-2669.
  • 7Wang A C, Dai X, Luu B, et al. Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation [ J ]. Am J Respir Cell Mol Biol, 2001, 24(6) : 688-693.
  • 8Cuzzocrea S, Pisano B, Dugo L, et al. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice [ J ]. Crit Care Med, 2004, 32(2) : 457-466.
  • 9钱桂生,王建春.急性呼吸窘迫综合征研究进展[J].第三军医大学学报,2004,26(10):843-844. 被引量:19

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部